Teymour Boutros-Ghali - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Teymour Boutros-Ghali’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Research and Development,
- Regenerative Medicine,
- Drug Discovery,
- Disruptive Innovation,
- Wellness,
- Women Founded,
- Enterprise Software,
- Immunotherapy,
- Computational Biology,
- Android,
- Cryptocurrency,
- Life Science,
- Engineering,
- Artificial Intelligence (AI),
- Robotics,
- Information Technology (IT),
- Computer-Aided Design (CAD),
- Analytics,
- 3D Technology,
- Mobile,
- Synthetic Biology,
- Software,
- Biotechnology,
- Construction,
- Medical Devices,
- Precision Medicine,
- Food and Beverage,
- Clinical Trials,
- FinTech,
- Research,
- Vaccines,
- Hardware,
- Logistics,
- Digital Health,
- Oil and Gas,
- Medical,
- Sensors,
- Information Technology,
- B2B,
- Therapeutics,
- Media and Entertainment,
- Machine Learning,
- Pharmaceuticals
Social media:
Past investments:
- Symbiome
- Seed Health
- Viome
- Kindred AI
- GuRu
- Pyka
- Docbot
- Epharmix
- MagicCube
- Synadia Communications
- Iota Biosciences
- DigiLens
- Gallant Pet
- Proprio Vision
- ŌURA
- Meta View
- BlueLine Grid
- Exo
- Meru Health
- Gali Health
- Atomiton
- Crowdz
- Terramera
- Bionaut Labs
- Solarea Bio
- Dreamscape Immersive
- Metawave
- Cloudleaf
- CloudMondo
- Mirror Emoji Keyboard
- Octi
- Mighty Buildings
- Elevian
- iviva medical
- BlueDot
- AliveCor
- Deep Longevity
- Singularity University
- Insilico Medicine
- Virgin Hyperloop
- Mojo Vision
Investor Profile
Teymour Boutros-Ghali is a Venture Capital, Private Equity Firm based in Santa Monica, California, United States with a diverse investment portfolio that includes companies such as Symbiome, Seed Health, Viome, Kindred AI, GuRu, Pyka, Docbot, Epharmix, MagicCube, Synadia Communications, Iota Biosciences, DigiLens, Gallant Pet, Proprio Vision, ŌURA, Meta ViewBlueLine Grid, Exo, Meru Health, Gali Health, Atomiton, Crowdz, Terramera, Bionaut Labs, Solarea Bio, Dreamscape Immersive, Metawave, Cloudleaf, CloudMondo, Mirror Emoji Keyboard, Octi, Mighty Buildings, Elevian, iviva medical, BlueDot, AliveCor, Deep Longevity, Singularity University, Insilico Medicine, Virgin Hyperloop, Mojo Vision, . Over time, Teymour Boutros-Ghali has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Teymour Boutros-Ghali is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Regenerative Medicine, Drug Discovery, Disruptive Innovation, Wellness, Women Founded, Enterprise Software, Immunotherapy, Computational Biology, Android, Cryptocurrency, Life Science, Engineering, Artificial Intelligence (AI), Robotics, Information Technology (IT), Computer-Aided Design (CAD), Analytics, 3D Technology, Mobile, Synthetic Biology, Software, Biotechnology, Construction, Medical Devices, Precision Medicine, Food and Beverage, Clinical Trials, FinTech, Research, Vaccines, Hardware, Logistics, Digital Health, Oil and Gas, Medical, Sensors, Information Technology, B2B, Therapeutics, Media and Entertainment, Machine Learning, Pharmaceuticals may find it worthwhile to explore potential connections with Teymour Boutros-Ghali, as their portfolio suggests a familiarity and interest in this area.
Understanding Teymour Boutros-Ghali’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
